Paradigm Biocapital Advisors LP Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$501.5B
Holdings
23
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (23 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LEGNLEGEND BIOTECH CORP | 978,596 | $53.8B | 10.73% | |
| 2 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,445,566 | $46.2B | 9.21% | |
| 3 | MRTXEURMIRATI THERAPEUTICS INC | 659,968 | $44.3B | 8.83% | |
| 4 | —SIERRA ONCOLOGY INC | 801,314 | $44.1B | 8.79% | |
| 5 | INCYINCYTE CORP | 556,043 | $42.2B | 8.42% | |
| 6 | ASNDASCENDIS PHARMA A/S | 432,170 | $40.2B | 8.01% | |
| 7 | UTHUNITED THERAPEUTICS CORP DEL | 163,066 | $38.4B | 7.66% | |
| 8 | ARGXARGENX SE | 88,816 | $33.7B | 6.71% | |
| 9 | IMCRIMMUNOCORE HLDGS PLC | 667,417 | $24.9B | 4.97% | |
| 10 | ARVNARVINAS INC | 517,406 | $21.8B | 4.34% | |
| 11 | BCYCBICYCLE THERAPEUTICS PLC | 1,048,516 | $17.6B | 3.51% | |
| 12 | SNDXSYNDAX PHARMACEUTICALS INC | 876,156 | $16.9B | 3.36% | |
| 13 | VRDNVIRIDIAN THERAPEUTICS INC | 1,306,569 | $15.1B | 3.01% | |
| 14 | MRUSMERUS N V | 452,244 | $10.2B | 2.04% | |
| 15 | ESPRESPERION THERAPEUTICS INC NE | 1,408,050 | $9.0B | 1.79% | |
| 16 | TGTXTG THERAPEUTICS INC | 1,964,709 | $8.3B | 1.66% | |
| 17 | NVLSEURALPINE IMMUNE SCIENCES INC | 826,779 | $7.0B | 1.40% | |
| 18 | ENTAENANTA PHARMACEUTICALS INC | 148,216 | $7.0B | 1.40% | |
| 19 | VORVOR BIOPHARMA INC | 1,304,300 | $6.5B | 1.29% | |
| 20 | OYSTOYSTER PT PHARMA INC | 1,333,330 | $5.8B | 1.15% | |
| 21 | GRCLGRACELL BIOTECHNOLOGIES INC | 783,445 | $4.3B | 0.86% | |
| 22 | LQDALIQUIDIA CORPORATION | 850,961 | $3.7B | 0.74% | |
| 23 | CCCCC4 THERAPEUTICS INC | 73,149 | $552.0M | 0.11% |